Literature DB >> 28559959

Traditional Chinese medicine for lipid metabolism disorders.

Yiping Li1, Xiaolong Wang1, Zhijie Shen1.   

Abstract

Dyslipidemia significantly contributes to the development of cardiovascular disease (CVD), which is the most common cause of morbidity and mortality in China. Statins are the first-line therapy for reducing LDL-C serum levels. However, they have adverse effects, which restrict their clinical application. Traditional Chinese medicine (TCM) preparations have been increasingly described for their beneficial effects in hyperlipidemic patients. Existing data show that the lipid-regulating effects of TCM may be related to: (1) inhibiting intestinal absorption of lipids; (2) reducing endogenous cholesterol synthesis; (3) regulating cholesterol transport; (4) promoting the excretion of cholesterol in the liver; (5) regulating transcription factors related to lipid metabolism. This study provides an overview of recent studies and elaborates the underlying mechanisms of lipid-regulation by TCM.

Entities:  

Keywords:  Dyslipidemia; traditional Chinese medicine; underlying mechanisms

Year:  2017        PMID: 28559959      PMCID: PMC5446491     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  63 in total

1.  Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis.

Authors:  S M Clee; N Bissada; F Miao; L Miao; A D Marais; H E Henderson; P Steures; J McManus; B McManus; R C LeBoeuf; J J Kastelein; M R Hayden
Journal:  J Lipid Res       Date:  2000-04       Impact factor: 5.922

2.  Potential synergistic effects of Chinese herbal prescription FTZ components detected in blood towards hepatic lipid-modulating targets.

Authors:  Laiyou Wang; Weiye Tao; Duosheng Luo; Yinming Hu; Weijian Bei; Jiao Guo
Journal:  Complement Ther Med       Date:  2014-08-13       Impact factor: 2.446

3.  Putting cholesterol in its place: apoE and reverse cholesterol transport.

Authors:  Robert W Mahley; Yadong Huang; Karl H Weisgraber
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  The antihypercholesterolemic effect of columbamine from Rhizoma Coptidis in HFHC-diet induced hamsters through HNF-4α/FTF-mediated CYP7A1 activation.

Authors:  Yue Wang; Yulong Han; Fangni Chai; Hongmei Xiang; Tao Huang; Shuming Kou; Bing Han; Xiaobao Gong; Xiaoli Ye
Journal:  Fitoterapia       Date:  2016-10-03       Impact factor: 2.882

5.  A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats.

Authors:  Jiao Guo; Weijian Bei; Yinming Hu; Chunping Tang; Wei He; Xiaobo Liu; Lihua Huang; Yang Cao; Xuguang Hu; Xunlong Zhong; Le Cao
Journal:  J Ethnopharmacol       Date:  2011-03-17       Impact factor: 4.360

6.  Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.

Authors:  Yan Zhou; Shijie Cao; Ying Wang; Peixiang Xu; Jiankun Yan; Wen Bin; Feng Qiu; Ning Kang
Journal:  Fitoterapia       Date:  2013-12-07       Impact factor: 2.882

7.  Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.

Authors:  Patrick M Moriarty; Eli M Roth; Adam Karns; Ping Ye; Shui-Ping Zhao; Yuhua Liao; David M Capuzzi; Harold E Bays; Fumin Zhang; Shaowen Liu; Alan J Reichman; Osvaldo A Brusco; Guoping Lu; Sam Lerman; Zhenwen Duan; Shuren Guo; Ping Lan Liu; Junxian Zhao; Yan Zhang; Simon Li
Journal:  J Clin Lipidol       Date:  2014-09-16       Impact factor: 4.766

8.  Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways.

Authors:  Kai He; Yinran Hu; Hang Ma; Zongyao Zou; Yubo Xiao; Yong Yang; Min Feng; Xuegang Li; Xiaoli Ye
Journal:  Biochim Biophys Acta       Date:  2016-06-07

9.  Effect of Centella asiatica on oxidative stress and lipid metabolism in hyperlipidemic animal models.

Authors:  Yun Zhao; Ping Shu; Youzhi Zhang; Limin Lin; Haihong Zhou; Zhentian Xu; Daqin Suo; Anzhi Xie; Xin Jin
Journal:  Oxid Med Cell Longev       Date:  2014-04-16       Impact factor: 6.543

10.  In vivo lipid regulation mechanism of polygoni multiflori radix in high-fat diet fed rats.

Authors:  Pei Lin; Yan Ran He; Jian Mei Lu; Na Li; Wan Gen Wang; Wen Gu; Jie Yu; Rong Hua Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

View more
  1 in total

1.  Astragalus Polysaccharides Inhibits Tumorigenesis and Lipid Metabolism Through miR-138-5p/SIRT1/SREBP1 Pathway in Prostate Cancer.

Authors:  Shanqi Guo; Baojie Ma; Xingkang Jiang; Xiaojiang Li; Yingjie Jia
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.